PL2851075T3 - Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu - Google Patents
Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanuInfo
- Publication number
- PL2851075T3 PL2851075T3 PL13790955T PL13790955T PL2851075T3 PL 2851075 T3 PL2851075 T3 PL 2851075T3 PL 13790955 T PL13790955 T PL 13790955T PL 13790955 T PL13790955 T PL 13790955T PL 2851075 T3 PL2851075 T3 PL 2851075T3
- Authority
- PL
- Poland
- Prior art keywords
- unsaturated
- preparation containing
- carbamoylmorphinan
- derivative
- carbamoylmorphinan derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012110417 | 2012-05-14 | ||
| EP13790955.2A EP2851075B1 (en) | 2012-05-14 | 2013-05-13 | Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative |
| PCT/JP2013/063278 WO2013172297A1 (ja) | 2012-05-14 | 2013-05-13 | ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2851075T3 true PL2851075T3 (pl) | 2022-02-21 |
Family
ID=49583702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13790955T PL2851075T3 (pl) | 2012-05-14 | 2013-05-13 | Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10952968B2 (pl) |
| EP (1) | EP2851075B1 (pl) |
| JP (1) | JP5818219B2 (pl) |
| CA (1) | CA2873961C (pl) |
| DK (1) | DK2851075T3 (pl) |
| ES (1) | ES2903149T3 (pl) |
| PL (1) | PL2851075T3 (pl) |
| TW (1) | TW201350120A (pl) |
| WO (1) | WO2013172297A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110325178B (zh) * | 2016-12-26 | 2022-05-13 | 盐野义制药株式会社 | 改善含量均一性的制剂的制造方法 |
| JP6131379B1 (ja) * | 2016-12-28 | 2017-05-17 | 森下仁丹株式会社 | ４，５−エポキシモルヒナン誘導体含有製剤 |
| JP7582961B2 (ja) * | 2019-11-20 | 2024-11-13 | 塩野義製薬株式会社 | ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有固形製剤 |
| WO2021172462A1 (ja) * | 2020-02-28 | 2021-09-02 | 塩野義製薬株式会社 | 術後の消化管の回復促進のための医薬組成物および方法 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4365060A (en) * | 1979-04-28 | 1982-12-21 | Shin-Etsu Chemical Co. Ltd. | Enterosoluble capsules |
| US4931286A (en) * | 1989-04-19 | 1990-06-05 | Aqualon Company | High gloss cellulose tablet coating |
| US5225201A (en) * | 1991-08-23 | 1993-07-06 | Minnesota Mining And Manufacturing Company | Salsalate tablet |
| US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
| TW442301B (en) | 1995-06-07 | 2001-06-23 | Sanofi Synthelabo | Pharmaceutical compositions containing irbesartan |
| WO2000071117A1 (en) * | 1999-05-21 | 2000-11-30 | Kissei Pharmaceutical Co., Ltd. | Immediate release medicinal compositions for oral use |
| US6740339B1 (en) * | 1999-06-18 | 2004-05-25 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| CA2350195C (en) | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| AR036312A1 (es) | 2001-08-31 | 2004-08-25 | Novartis Ag | Composicion farmaceutica |
| US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
| PA8576201A1 (es) | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
| JP3759949B2 (ja) * | 2002-12-17 | 2006-03-29 | 湧永製薬株式会社 | 遮光剤及び皮膜組成物 |
| CN102525993B (zh) * | 2003-04-24 | 2017-04-12 | 佳高泰克有限公司 | 具有限定内核几何形状的缓释片剂 |
| ATE445393T1 (de) * | 2003-04-24 | 2009-10-15 | Jagotec Ag | Tablette mit gefärbtem kern |
| RS20060009A (sr) | 2003-07-11 | 2008-06-05 | F.Hoffmann-La Roche Ag., | Oralni oblik za doziranje sakvinavir mezilata |
| DE602005018387D1 (de) | 2004-10-06 | 2010-01-28 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung, verfahren zu ihrer hdihydropyridin-verbindung in einer medizinischen zusammensetzung |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| JP4214128B2 (ja) | 2005-04-27 | 2009-01-28 | 大日本住友製薬株式会社 | 光安定性の向上した組成物 |
| WO2006126529A1 (ja) | 2005-05-25 | 2006-11-30 | Shionogi & Co., Ltd. | ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体 |
| US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
| US8637078B2 (en) * | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
| CN101340899A (zh) * | 2005-12-20 | 2009-01-07 | 卫材R&D管理有限公司 | 含有脂溶性药物的口腔内速崩片 |
| WO2008114800A2 (en) * | 2007-03-13 | 2008-09-25 | Takeda Pharmaceutical Company Limited | Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| JP5099127B2 (ja) * | 2007-04-26 | 2012-12-12 | 東レ株式会社 | ４，５−エポキシモルヒナン誘導体を含有する安定な固形製剤 |
| KR101520311B1 (ko) | 2007-05-21 | 2015-05-14 | 도레이 카부시키가이샤 | 특정 유기산을 함유하는 경구 제제, 및 경구 제제의 용출성과 화학적 안정성의 개선 방법 |
| WO2008152619A1 (en) * | 2007-06-13 | 2008-12-18 | Meditor Pharmaceuticals Ltd. | Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives |
| CL2008003230A1 (es) * | 2007-11-01 | 2009-11-27 | Sanofi Aventis Healthcare Pty Ltd | Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta. |
| US20100285119A1 (en) * | 2008-01-11 | 2010-11-11 | Jubilant Organosys Ltd. | Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same |
| JP5401327B2 (ja) | 2008-02-11 | 2014-01-29 | 大日本住友製薬株式会社 | 溶出性の改善された錠剤 |
| AR073380A1 (es) * | 2008-09-25 | 2010-11-03 | Takeda Pharmaceutical | Composicion farmaceutica solida. comprimido multicapa |
| CN102196811B (zh) | 2008-10-24 | 2014-03-19 | 东丽株式会社 | 含有4,5-环氧基吗啡烷衍生物的稳定片剂 |
| JP5452050B2 (ja) | 2009-03-27 | 2014-03-26 | 杏林製薬株式会社 | イミダフェナシンを含有する口腔内崩壊錠 |
| US20120029032A1 (en) * | 2009-03-27 | 2012-02-02 | Kyorin Pharmaceutical Co., Ltd. | Matrix-type sustained release preparation containing basic additive |
| JP5644167B2 (ja) | 2009-04-21 | 2014-12-24 | 大正製薬株式会社 | 溶出改善されたケトチフェン又はその塩を含有する固形製剤 |
| EP2501237A1 (en) * | 2009-11-06 | 2012-09-26 | Infinity Pharmaceuticals, Inc. | Oral formulations of a hedgehog pathway inhibitor |
| JP2011105694A (ja) | 2009-11-12 | 2011-06-02 | Takada Seiyaku Kk | オロパタジン経口固形組成物 |
| WO2011087705A2 (en) * | 2009-12-22 | 2011-07-21 | Fmc Corporation | Fine particle croscarmellose and uses thereof |
| RU2643807C1 (ru) | 2010-11-12 | 2018-02-06 | Сионоги Энд Ко., Лтд. | Кристаллы производных 6,7-ненасыщенного-7-карбамоилморфинана и способ их получения |
| AU2013350329A1 (en) * | 2012-11-26 | 2015-07-02 | Progel Pty Ltd | Coating composition |
-
2013
- 2013-05-13 CA CA2873961A patent/CA2873961C/en active Active
- 2013-05-13 ES ES13790955T patent/ES2903149T3/es active Active
- 2013-05-13 WO PCT/JP2013/063278 patent/WO2013172297A1/ja not_active Ceased
- 2013-05-13 PL PL13790955T patent/PL2851075T3/pl unknown
- 2013-05-13 JP JP2014515611A patent/JP5818219B2/ja active Active
- 2013-05-13 EP EP13790955.2A patent/EP2851075B1/en active Active
- 2013-05-13 US US14/401,388 patent/US10952968B2/en active Active
- 2013-05-13 DK DK13790955.2T patent/DK2851075T3/da active
- 2013-05-14 TW TW102117071A patent/TW201350120A/zh unknown
-
2018
- 2018-10-12 US US16/158,786 patent/US11116727B2/en active Active
-
2021
- 2021-01-25 US US17/156,892 patent/US12350377B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5818219B2 (ja) | 2015-11-18 |
| US12350377B2 (en) | 2025-07-08 |
| US20190046452A1 (en) | 2019-02-14 |
| CA2873961C (en) | 2017-09-26 |
| EP2851075B1 (en) | 2021-12-01 |
| DK2851075T3 (da) | 2022-01-31 |
| US10952968B2 (en) | 2021-03-23 |
| JPWO2013172297A1 (ja) | 2016-01-12 |
| US11116727B2 (en) | 2021-09-14 |
| EP2851075A1 (en) | 2015-03-25 |
| WO2013172297A1 (ja) | 2013-11-21 |
| US20210145753A1 (en) | 2021-05-20 |
| EP2851075A4 (en) | 2015-10-21 |
| TW201350120A (zh) | 2013-12-16 |
| ES2903149T3 (es) | 2022-03-31 |
| US20150216804A1 (en) | 2015-08-06 |
| CA2873961A1 (en) | 2013-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2875029B8 (en) | 5,5-heteroaromatic anti-infective compounds | |
| ZA201409248B (en) | Novel indanesulfamide derivative | |
| ZA201306229B (en) | Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines | |
| GB201222141D0 (en) | Further addtions 2 | |
| GB201214120D0 (en) | Yota 070812 | |
| SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors | |
| DK2851075T3 (da) | Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat | |
| TWM432338U (en) | M1010701_3919 | |
| GB201200518D0 (en) | Wizz-through 2 (cielings) | |
| GB201200323D0 (en) | Easihang 45?/90? | |
| GB201220196D0 (en) | Magno-rebel 1 | |
| GB201220558D0 (en) | Novel compounds 1 | |
| GB201214054D0 (en) | Pakaging 0 | |
| GB201208532D0 (en) | SockScreen 2 | |
| GB201210424D0 (en) | Poop - pole N?2 | |
| GB201206581D0 (en) | CityJaw 1830 | |
| GB201206730D0 (en) | Novel compounds 1 | |
| GB201200834D0 (en) | Vinsole 3 | |
| GB201210088D0 (en) | Odontalgic preparation | |
| TWM432299U (en) | M1010701_3919 | |
| TWM432411U (en) | M1010701_3919 | |
| TWM432248U (en) | M1010701_3919 | |
| TWM432309U (en) | M1010701_3919 | |
| TWM432298U (en) | M1010701_3919 | |
| TWM432312U (en) | M1010701_3919 |